Tag Archives: warns

Ozempic and Wegovy: FDA warns of increase in off-brand versions

Share on PinterestThe FDA has issued a warning against compound drugs similar to Ozempic and Wegovy that haven’t been tested for safety or efficacy. Terry Vine/Getty Images The FDA has issued a warning on GLP-1 drugs similar to Ozempic and Wegovy. These drugs differ from FDA-approved Ozempic and Wegovy because they are made by online… Read More »

The FDA warns against the compound semaglutide

The United States Food and Drug Administration (FDA) warns against going to compounding pharmacies for generic versions of semaglutide, the active ingredient in Wegovy and Ozempic. Compound drugs can mix, combine, or alter ingredients to create drugs that are tailored to the needs of individual patients. Medicines can be compounded when there is a shortage… Read More »